ELDN: Presents Kidney Transplant Data
Eledon Pharma presents new long-term data from Phase 2 BESTOW clinical program evaluating Tegoprubart in patients undergoing kidney transplantation at ATC 2026
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.